FDA Drug Class III — Least Serious

Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01

Hazard

Labeling: Incorrect or Missing Package Insert: An outdated version of a patient outsert was used when packaged.

Products

Loxitane Capsules, Loxapine Succinate Capsules, 10mg base, 100 count bottle, Rx only, Watson Laboratories Inc., Corona, CA 92880 NDC # 52544-495-01
Brand
Watson Laboratories Inc
UPC
Lot # 22478A

Units Affected

7,262 bottles